Naroparcil
Product Specifications
CAS Number
120819-70-7
Target
Factor Xa|||Thrombin
Related Pathways
Metabolism|||Proteases/Proteasome
Purity
0.9999
Bioactivity
Naroparcil, an orally available thioglycoside analog of 4-methylumbelliferyl ?-D-xyloside, showed antithrombotic effects in the Wessler sludge model of venous thrombosis (jugular vein) .Naroparcil enhanced the formation of the thrombin/heparin cofactor II complex, induced dermatophyte sulfate-like substances in plasma from treated rabbits appearance, but reduced the formation of thrombin/antithrombin III complexes in plasma incubated with (125I) -human alpha-thrombin.
Smiles
S(C1=CC=C(C(=O)C2=CC=C(C#N)C=C2)C=C1)[C@H]3[C@H](O)[C@@H](O)[C@H](O)CS3
Molecular Formula
C19H17NO4S2
Molecular Weight
387.47
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1032492-01 0.02 mg (E-Coli)
Recombinant Polynucleobacter necessarius Ribosome-binding factor A (rbfA)
Ask
View Details MBS1032492-02 0.1 mg (E-Coli)
Recombinant Polynucleobacter necessarius Ribosome-binding factor A (rbfA)
Ask
View Details 
MBS1032492-03 0.02 mg (Yeast)
Recombinant Polynucleobacter necessarius Ribosome-binding factor A (rbfA)
Ask
View Details 
MBS1032492-04 0.1 mg (Yeast)
Recombinant Polynucleobacter necessarius Ribosome-binding factor A (rbfA)
Ask
View Details